Objectives: This presentation aims to provide a comprehensive summary of the most recent research on the mechanisms and applications of exosomes in scars treatment, as well as explore the most effective methods of administration in combination with other therapeutic approaches.
Introduction: Severe inflammation and injury can result in disfiguring scarring, leading to cosmetic, functional, and even psychological impact. Despite advancements in medicine, scar treatment remains a significant challenge. Exosomes are cell-derived nanoscale vesicles carrying various biomolecules.with the capability to communicate with adjacent or distant cells. The exosome can modulate essential cellular processes, such as proliferation, differentiation, migration, and cell death.
Materials / method: Our experience in exosome-based dermatology and aesthetic applications includes treating over 1500 scar patients with various types of scars in our clinic. This study was conducted using different treatment protocols, including exosomes alone or in combination with microneedling radiofrequency or CO2 laser.
Classification of scar to hypertrophic, keloid and atrophic is paramount in determining an appropriate treatment strategy.
Exosomes in this study were acquired from human ASC-CM by ExoSCRT™ technology (ExoCoBio Inc., Seoul, Republic of Korea)
Results: Wound healing process involves cell migration, proliferation, extracellular matrix remodeling, angiogenesis and re-epithelialization. However, some risk factors can impair this process, leading to pathological fibrosis and scarring. Research has shown that exosomes exhibit paracrine effects, helping to regulate inflammation, modifying the fibroblast activation, enhance collagen production and promote neovascularization and re-epithelialization.Therefore, exosomes can be therapeutic options in regenerative medicine and aesthetics, such as wound healing and scars,
Conclusion: Exosomes represent a promising therapeutic approach for scar treatment due to their ability to regulate key cellular processes such as inflammation, fibroblast activation, while current treatment options for scar remain limited. Our clinical experience with over 1500 scar patients highlight the potential of exosomes as an effective treatment modality.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。